Main Menu

Clinical trials

The ICR Clinical Trials and Statistics Unit (ICR-CTSU) leads the design, conduct and analysis of phase II and III national and international cancer clinical trials. Our findings directly influence clinical practice within the NHS and worldwide.

This page highlights recent news stories and blog posts that concern clinical trials that involve the ICR.

Blog Caption for:

"I was hoping for 12-18 months… here I am 14 years later" – Sue’s ovarian cancer story

News Caption for: World's first trial to test multiple treatments for brain cancers

World's first trial to test multiple treatments for brain cancers

News Caption for: New drug combination offers hope to women with rare treatment-resistant ovarian cancer

New drug combination offers hope to women with rare treatment-resistant ovarian cancer

Blog Caption for: 100 days in – what do we need from the Government to enable cancer research to thrive?

100 days in – what do we need from the Government to enable cancer research to thrive?

News Caption for: New genetic testing pathways could ensure patients get personalised treatments and help to catch more BRCA-linked cancer cases

New genetic testing pathways could ensure patients get personalised treatments and help to catch more BRCA-linked cancer cases...

News Caption for: MHRA approves first-in-class breast cancer drug

MHRA approves first-in-class breast cancer drug

News Caption for: New screening trial to save thousands of men’s lives from prostate cancer

New screening trial to save thousands of men’s lives from prostate cancer

News Caption for: ICR researcher wins prestigious clinical science award

ICR researcher wins prestigious clinical science award

Feature Caption for: Capivasertib – a huge success story for UK science

Capivasertib – a huge success story for UK science